Outlook Therapeutics director Haddadin Yezan Munther buys $24,145 in shares

Markets Investing.com By Investing.com 03 Jun 2026 22:07 1 min read

Outlook Therapeutics director Haddadin Yezan Munther buys $24,145 in shares

Outlook Therapeutics director Haddadin Yezan Munther buys $24,145 in shares

Outlook Therapeutics director Haddadin Yezan Munther buys $24,145 in shares

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.